Discovery of novel selective GPR120 agonists with potent anti-diabetic activity by hybrid design
作者:Ren Sheng、Liu Yang、Yanchun Zhang、Enming Xing、Rui Shi、Xiaoan Wen、Heyao Wang、Hongbin Sun
DOI:10.1016/j.bmcl.2018.06.047
日期:2018.8
is an attractive target for the treatment of type 2 diabetes. In this study, a series of biphenyl derivatives were designed, synthesized by hybrid design. The selected compound 6a exhibited potent GPR120 agonist activity (EC50 = 93 nM) and high selectivity over GPR40. The results of oral glucose tolerance test (OGTT) demonstrated that 6a exhibited significant glucose-lowering effect in glucose-loaded
GPR120是治疗2型糖尿病的有吸引力的靶标。在这项研究中,设计了一系列联苯衍生物,通过杂化设计合成。所选择的化合物6a表现出有效的GPR120激动剂活性(EC 50 = 93nM),并且相对于GPR40具有高选择性。口服葡萄糖耐量试验(OGTT)的结果表明6a在负载葡萄糖的ICR雄性小鼠中显示出显着的降糖作用。还提出了结构-活性关系的分析。化合物6a值得进一步的生物学评估和结构修饰。